Marius Konig

Sankt Gallen, SG, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Anti-Integrin αvβ6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study.

Anti-Integrin αvβ6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study.

Journal: Alimentary pharmacology & therapeutics

Published: June 12, 2026

LAMAS (Light, Activity, Meals, & Sleep) timings & burnout, anxiety, and depression in teachers: Protocol for a cross-sectional study.

LAMAS (Light, Activity, Meals, & Sleep) timings & burnout, anxiety, and depression in teachers: Protocol for a cross-sectional study.

Journal: PloS one

Published: December 16, 2025

Predictors, mediators, effect modifiers and preventive actions regarding secondary school teacher burnout, anxiety and depression-protocol for a systematic scoping review.

Predictors, mediators, effect modifiers and preventive actions regarding secondary school teacher burnout, anxiety and depression-protocol for a systematic scoping review.

Journal: BMJ open

Published: October 09, 2025

Burnout, anxiety and depression in secondary school teachers in Europe during the COVID-19 pandemic: a systematic scoping review & perspective of preventive occupational medicine.

Burnout, anxiety and depression in secondary school teachers in Europe during the COVID-19 pandemic: a systematic scoping review & perspective of preventive occupational medicine.

Journal: Journal of occupational medicine and toxicology (London, England)

Published: September 26, 2025

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

Journal: Vaccines

Published: May 24, 2025

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

Journal: Vaccines

Published: October 02, 2024

First Description of Upadacitinib as Treatment for Collagenous Colitis with a Concomitant Lymphocytic Disorder of the Upper Gastrointestinal Tract.

First Description of Upadacitinib as Treatment for Collagenous Colitis with a Concomitant Lymphocytic Disorder of the Upper Gastrointestinal Tract.

Journal: Case reports in gastroenterology

Published: September 02, 2024

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

Journal: Alimentary pharmacology & therapeutics

Published: August 28, 2024

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.

Journal: Vaccines

Published: June 07, 2024

STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.

STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.

Journal: Alimentary pharmacology & therapeutics

Published: July 03, 2023

Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.

Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.

Journal: Alimentary pharmacology & therapeutics

Published: August 23, 2022

Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation - real-life data from a survey in Eastern Switzerland.

Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation - real-life data from a survey in Eastern Switzerland.

Journal: Swiss medical weekly

Published: October 18, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026